- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech High Insider Buying
Swedish Pharmaceuticals & Biotech High Insider Buying
Results
8
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
8 companies
AddLife
Market Cap: SEK 23.3b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 190.90
7D
5.6%
1Y
15.3%
Swedencare
Market Cap: SEK 6.3b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 39.50
7D
-2.1%
1Y
-14.6%
Egetis Therapeutics
Market Cap: SEK 1.8b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.01
7D
-6.2%
1Y
2.0%
Oncopeptides
Market Cap: SEK 1.1b
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 4.79
7D
-8.9%
1Y
127.3%
Mendus
Market Cap: SEK 377.6m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 7.25
7D
5.1%
1Y
-11.4%
Promimic
Market Cap: SEK 314.6m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 16.65
7D
9.5%
1Y
-52.4%
OncoZenge
Market Cap: SEK 78.0m
A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 6.17
7D
-2.4%
1Y
1.0%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%